SCHEMBL4544345

SCHEMBL4544345

COc1cc(-c2ccc(OCc3ccccc3)cc2)on1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMPD1 P17405 1/20 0.59
NPC1 O15118 3/20 0.51
RAB9A P51151 3/20 0.51
CYP1A2 P05177 2/20 0.49
CYP1A1 P04798 1/20 0.49
CYP1B1 Q16678 1/20 0.49
MAPT P10636 3/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
TDP1 Q9NUW8 2/20 0.49
CXCR1 P25024 2/20 0.48
GSTP1 P09211 1/20 0.48
MAOB P27338 1/20 0.47
ENPP3 O14638 1/20 0.46
ENPP1 P22413 1/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
PTGS1 P23219 2/20 0.46
PTGS2 P35354 2/20 0.46
POLB P06746 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1417136 0.88 SMPD1 (0.56) SMPD1NPC1RAB9ACYP1A2CYP1A1
SCHEMBL27495196 0.83 SMPD1 (0.56) SMPD1NPC1RAB9AMAPTL3MBTL1
Hydrochloric Acid SCHEMBL8375536 0.82 SMPD1 (0.55) SMPD1NPC1RAB9AL3MBTL1SMN1; SMN2
SCHEMBL4544348 0.81 SMPD1 (0.59) SMPD1NPC1RAB9ACYP1A2MAPT
SCHEMBL10342451 0.81 RAB9A (0.58) NPC1RAB9AMAPTL3MBTL1SMN1; SMN2
SCHEMBL1417062 0.81 SMPD1 (0.65) SMPD1NPC1RAB9ACYP1A2MAPT
SCHEMBL6029891 0.80 SMPD1 (0.74) SMPD1MAPTSMN1; SMN2MEN1KMT2A
SCHEMBL1566837 0.78 NOTUM (0.66) SMPD1NPC1RAB9ACYP1A2MAPT
SCHEMBL1222200 0.78 SMPD1 (0.77) SMPD1MAPTGSTP1ALDH1A1HPGD
SCHEMBL28388709 0.75 SMPD1 (0.68) SMPD1MAPTL3MBTL1MAOBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9150563-B2 Nitrogen-containing aromatic heterocyclyl compound DAIICHI SANKYO COMPANY, LIMITED (JP) 2015-10-06 US disclosed
US-20140187592-A1 NITROGEN-CONTAINING AROMATIC HETEROCYCLYL COMPOUND DAIICHI SANKYO COMPANY, LIMITED (JP) 2014-07-03 US disclosed
US-8648103-B2 Nitrogen-containing aromatic heterocyclyl compound DAIICHI SANKYO COMPANY, LIMITED (JP) 2014-02-11 US disclosed
US-20120108639-A1 NITROGEN-CONTAINING AROMATIC HETEROCYCLYL COMPOUND DAIICHI SANKYO COMPANY, LIMITED (JP) 2012-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140187592-A1 NITROGEN-CONTAINING AROMATIC HETEROCYCLYL COMPOUND NPR1, NPR3, NPC1 SMPD1 347/4885NPC1 3/4885RAB9A 1146/4885
US-20120108639-A1 NITROGEN-CONTAINING AROMATIC HETEROCYCLYL COMPOUND NPR1, NPR3, NPPA SMPD1 243/4885NPC1 8/4885RAB9A 1456/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.